Kingswood Capital Management, LP and Forager Fund, L.P. a fund managed by Forager Capital Management LLC completed the acquisition of Quipt Home Medical Corp..

Kingswood Capital Management, LP and Forager Fund, L.P. a fund managed by Forager Capital Management LLC entered into a definitive agreement to acquire Quipt Home Medical Corp. (TSX:QIPT) for approximately $170 million on December 14, 2025. A cash consideration valued at $3.65 per share will be paid by Kingswood Capital Management, LP. Upon closing of the transaction, the Purchaser intends to cause the Shares to be delisted from the Toronto Stock Exchange and the NASDAQ Capital Market, de-registered under the Securities Exchange Act of 1934, as amended, and to cause Quipt to submit an application to cease to be a ?reporting issuer? under applicable Canadian securities laws. The Arrangement Agreement also provides for the payment by the Company to Purchaser of a termination fee of $6.950 million if the Arrangement Agreement is terminated.

The Board unanimously recommends that Quipt shareholders vote in favor of the transaction at the special meeting to be called to approve the transaction. The transaction will be implemented by way of statutory plan of arrangement under the Business Corporations Act (British Columbia) and is subject to court approval and the approval of at least 66 2/3% of the votes cast by Quipt shareholders present in person or by proxy at the Meeting, as well as by a simple majority of the votes cast by the Quipt shareholders. The transaction is expected to close during the first half of 2026, subject to customary closing conditions, including receipt of required shareholder, regulatory and court approvals. The Parties will cause to be made, as promptly as practicable after the date of this Agreement and, in any event, within twenty (20) Business Days, all filings, notifications, and submissions required under the HSR Act and third-party consents. As on March 3, 2026, the transaction has been approved the shareholders of Quipt Home Medical and Quipt Home Medical is scheduled to seek a final order of the Supreme Court of British Columbia approving the Arrangement on March 5, 2026. As of March 5, 2026, Supreme Court of British Columbia approve the transaction.

Grant McGlaughlin, Zach Austin of Fasken Martineau DuMoulin LLP, in Canada, are legal counsel to Kingswood, Forager, and the Purchaser. UBS Investment Bank is acting as exclusive financial advisor to Kingswood. Truist Securities, Inc.. Evans & Evans is acting as financial advisor, and Truist and Evans & Evans, Inc acting as fairness opinion to Quipt. Frederic L. Levenson, Michael Hacker, Ann Marie Brodarick of McDermott Will & Schulte LLP acted as legal advisor to Kingswood Capital Management, LP, Robbie Grossman, Nishnick, Sydney A. Kert of DLA Piper (Canada) LLP acted as legal advisor to Quipt Home Medical Corp, Larry Nishnick of DLA Piper LLP (US) acted as legal advisor to Quipt Home Medical Corp, Maynard Nexsen P.C acted as legal advisor to Forager Capital Management, LLC. Goodmans LLP acted as legal advisor for board of Quipt Home Medical Corp. Carson Proxy Advisors Ltd. acted as proxy solicitor for Quipt Home Medical Corp.

Kingswood Capital Management, LP and Forager Fund, L.P. a fund managed by Forager Capital Management LLC completed the acquisition of Quipt Home Medical Corp. (TSX:QIPT) on March 16, 2026. Quipt Home Medicalshares will be delisted from the NASDAQ Capital markets and Toronto Stock Exchange.